Provision of Resources in the Implementation of Tuberculosis-Multi Drugs Resistance Treatment Service in “X” Hospital
DOI:
https://doi.org/10.18196/jmmr.83103Keywords:
Tuberculosis - Multi, Drugs Resistance Treatment, Hospital ServiceAbstract
The purpose of the study is to evaluate the provision of resources in the implementation of Tuberculosis - Multi Drugs Resistance (MDR-TB) treatment service in “X” Hospital. The research type is qualitative research with in-depth interviews, observations, and documentation. The main informants are health workers who have been trained and involved in MDR-TB treatment service while the triangulation informants are MDR-TB patients and the Head of Community Health Center. Existing data is collected, reduced, presented, evaluated, drawn conclusion and verified with 5 components of resources studied, namely the components of labor, facilities, logistics, funding and work methods or procedures. In this study, information was obtained that the implementation of MDR-TB treatment service in “X” Hospital must be supported by adequate preparation of resources by following applicable regulations. Therefore, an appropriate and measurable planning mechanism is needed so that in the preparation of resource requirements namely personnel, funding, facilities and logistics, as well as working methods or procedures in MDR-TB treatment service, can be calculated accurately and measurably to develop service.
References
World Health Organization. Global Health TB Report. WHO. 2018.
Arda Yuni IDAM. Hubungan Fase Pengobatan TB dan Pengetahuan tentang MDR TB dengan Kepatuhan Pengobatan Pasien TB (Studi di Puskesmas Perak Timur). J Berk Epidemiol. 2016;4(3):301–12.
Kementerian Kesehatan RI. Peraturan Menteri Kesehatan Nomor 13 Tahun 2013 tentang Pedoman Manajemen Terpadu Pengendalian Tuberkulosis Resistan Obat. Kementerian Kesehatan RI 2013.
Kementerian Kesehatan RI. Peraturan Menteri Kesehatan Nomor 72 Tahun 2016 tentang Penanggulangan Tuberkulosis. Kementerian Kesehatan RI 2016 p. 31–48.
Otu AA. Is The Directly Observed Therapy Short Course (DOTs) An Effective Strategy for Tuberculosis Control in A Developing Country? Asian Pacific J Trop Dis. 2013;3(3):227–31.
Prameswari A. The Evaluation of Directly Observed Treatment Short-Course (DOTS) Implementation for TB in Hospital X. J Medicoeticolegal dan Manaj Rumah Sakit. 2018;7(2):93–101.
Vries G de, Tsolova S, Anderson LF, Gebhard AC, Heldal E, Hollo V, et al. Health System Factors Influencing Management of Multidrug-Resistant Tuberculosis in Four European Union Countries - Learning from Country Experiences. BMC Public Health. 2017;17(334):1–12.
Utomo GC, Joebagyo H, Murti B. Case Study on Multi-Drug Resistance Tuberculosis in Grobogan, Central Java. J Epidemiol Public Heal. 2017;2(3):186–200.
Akshata JS, Chakrabarthy A. Management of Multidrug Resistant Tuberculosis (MDR-TB) – Monitoring is The Key to Successful Outcome. Egypt J Chest Dis Tuberc [Internet]. 2016;65:447–50. Available from: http://dx.doi.org/10.1016/j.ejcdt.2015.12.018
El-Din MAT, Halim HAA-E, El-Tantawy AM. Adverse Reactions among Patients being Treated for Multi-drug Resistant Tuberculosis in Egypt from July 2006 to January 2009. Egypt J Chest Dis Tuberc [Internet]. 2015;64:657–64. Available from: http://dx.doi.org/10.1016/j.ejcdt.2015.05.011
Karuniawati H, Sudjono TA, Utami HN, Pangastuti RA. Risk Factors for Multidrug Resistant (MDR) in Tuberculosis Patients at Public Hospitals in Indonesia. Adv Sci Lett. 2017;23(12):12469–73.
Munir SM, Nawas; A, Soetoyo; DK. Pengamatan Pasien Tuberkulosis Paru dengan Multidrug Resistant (TB-MDR) di Poliklinik Paru RSUP Persahabatan. J Respirologi Indones. 2010;30(2):92–104.
Yang Y, Zhou C, Shi L, Meng H, Yan H. Prevalence and Characterization of Drug-Resistant Tuberculosis in A Local Hospital of Northeast China. Int J Infect Dis [Internet]. 2014;22:83–6. Available from: http://dx.doi.org/10.1016/j.ijid.2013.12.015
Moleong LJ. Metodologi Penelitian Kualitatif (Edisi Revisi). PT. Remaja Rosda Karya; 2017.
Sirait N, Parwati I, Dewi NS, Suraya N. Validitas Metode Polymerase Chain Reaction GeneXpert MTB/RIF pada Bahan Pemeriksaan Sputum untuk Mendiagnosis Multidrug Resistant Tuberculosis. Maj Kedokt Bandung. 2014;45(4):234–9.
Cox H, Moshabela M, Nicol M, Vanleeuw L, Dickson-Hall L, Kielmann K, et al. Drug-Resistant Tuberculosis in South Africa : History, Progress and Opportunities for achieving Universal Access to Diagnosis an effective Treatment. SAHR. 2017;157–68.
Evans D, Sineke T, Schnippel K, Berhanu R, Govathson C, Black A, et al. Impact of Xpert MTB/RIF and Decentralized Care on Linkage to Care and Drug-Resistant Tuberculosis Treatment Outcomes in Johannesburg, South Africa. BMC Health Serv Res. 2018;18:1–12.
Vergara Gómez A, González-Martín J, García-Basteiro AL. Xpert ® MTB/RIF : Usefulness for The Diagnosis of Tuberculosis and Resistance to Rifampicin. Med Clínica (English Ed [Internet]. 2017;149(9):399–405. Available from: http://dx.doi.org/10.1016/j.medcle.2017.09.021
Saeed M, Ahmad M, Iram S, Riaz S, Akhtar M, Aslam M. GeneXpert Technology : A Breakthrough for The Diagnosis of Tuberculous Pericarditis and Pleuritis in Less than 2 Hours. Saudi Med J. 2017;38(7):699–705.
Lebina L, Fuller N, Osoba T, Scott L, Motlhaoleng K, Rakgokong M, et al. The Use of Xpert MTB/Rif for Active Case Finding among TB Contacts in North West Province, South Africa. Tuberc Res Treat. 2016;1–6.
Narasimooloo R, Ross A. Delay in Commencing Treatment for MDR TB at A Specialised TB Treatment Centre in KwaZulu-Natal. SAMJ. 2012;102(6):360–2.
Htun YM, Khaing TMM, Yin Y, Myint Z, Aung ST, Hlaing TM, et al. Delay in Diagnosis and Treatment among Adult Multidrug Resistant Tuberculosis Patients in Yangon Regional Tuberculosis Center - Myanmar : A Cross-Sectional Study. BMC Health Serv Res. 2018;18(878):1–13.
Naidoo P, Van Niekerk M, Du Toit E, Beyers N, Leon N. Pathways to multidrug-resistant tuberculosis diagnosis and treatment initiation: A qualitative comparison of patients’ experiences in the era of rapid molecular diagnostic tests. BMC Health Serv Res [Internet]. 2015;15(1):1–13. Available from: http://dx.doi.org/10.1186/s12913-015-1145-0
Jatau B, Avong Y, Ogundahunsi O, Shah S, Smith KT, Van Den Bergh R, et al. Procurement and Supply Management System for MDR-TB in Nigeria: Are The Early Warning Targets for Drug Stock Outs and Over Stock of Drugs being Achieved? PLoS One. 2015;10(6):1–10.
Kementerian Kesehatan RI. Petunjuk Teknis Manajemen Terpadu Pengendalian Tuberkulosis Resistan Obat. 2014.
Tamsil TA, Nawas A, Sutoyo DK. Pengobatan Multidrugs Resistant Tuberculosis (MDR-TB) dengan Paduan Jangka Pendek Multidrugs Resistant Tuberculosis (MDR-TB) Treatment with Short Term Regimen. J Respirasi Indones [Internet]. 2014;34:109–21. Available from: http://jurnalrespirologi.org/wp-content/uploads/2015/02/JRI-2014-34-2-109-121.pdf
Downloads
Published
Issue
Section
License
Copyright (c) 2019 JMMR (Jurnal Medicoeticolegal dan Manajemen Rumah Sakit)
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
